{"id":{"repo_id":"rosario","oai_identifier":"oai:repository.urosario.edu.co:10336/42088"},"canonical_url":"https://search.dev.ndltd.org/etd/rosario/oai:repository.urosario.edu.co:10336/42088","repository":{"repo_id":"rosario","name":"Universidad del Rosario","base_url":"https://repository.urosario.edu.co/oai/request"},"display":{"title":"Caracterización y desenlaces asociados al desarrollo de miocarditis en una cohorte retrospectiva. Fundación Cardioinfantil - Lacardio 2017 - 2022","abstract":"La miocarditis es un trastorno inflamatorio del miocardio que puede ocurrir secundario a una infección, respuesta inmune o toxicidad. Registros globales de carga de enfermedad han reportado una incidencia de 14 a 22 casos por 100.000 pacientes, 2/3 siendo hombres entre la tercera y cuarta década de la vida (1). Puede presentarse de forma, aguda, subaguda, crónica o fulminante según el tiempo de evolución y su severidad, siendo la miocarditis aguda y fulminante aquellas mayormente asociadas a cuadro complicados por shock cardiogénico y representando una causa importante de morbimortalidad cardiovascular en adultos jóvenes (2). Por lo cual este trabajo busca describir las características y desenlaces presentes en adultos con miocarditis aguda en una cohorte retrospectiva de la fundación Cardioinfantil – Lacardio 2017-2022.","abstract_html":"La miocarditis es un trastorno inflamatorio del miocardio que puede ocurrir secundario a una infección, respuesta inmune o toxicidad. Registros globales de carga de enfermedad han reportado una incidencia de 14 a 22 casos por 100.000 pacientes, 2/3 siendo hombres entre la tercera y cuarta década de la vida (1). Puede presentarse de forma, aguda, subaguda, crónica o fulminante según el tiempo de evolución y su severidad, siendo la miocarditis aguda y fulminante aquellas mayormente asociadas a cuadro complicados por shock cardiogénico y representando una causa importante de morbimortalidad cardiovascular en adultos jóvenes (2). Por lo cual este trabajo busca describir las características y desenlaces presentes en adultos con miocarditis aguda en una cohorte retrospectiva de la fundación Cardioinfantil – Lacardio 2017-2022.","abstract_has_math":false,"creators":["Casallas Angel, Ingrid Lizeth","Oliver Hernández, Gabriel Antonio"],"institution":"Universidad del Rosario","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024-01-15","date_published":"2024-01-15","updated_at":"2026-07-27T20:46:27Z","subjects":["Miocarditis aguda","Infección viral","Resonancia magnética cardiaca","Electrocardiografía","Ecocardiografía","Acute myocarditis","Viral infection","Cardiac magnetic resonance","Electrocardiography","Echocardiography"],"languages":["spa"],"rights":["info:eu-repo/semantics/openAccess"],"rights_urls":["http://creativecommons.org/licenses/by-nc-sa/4.0/"],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://repository.urosario.edu.co/handle/10336/42088"],"render_values":[{"text":"https://repository.urosario.edu.co/handle/10336/42088","href":"https://repository.urosario.edu.co/handle/10336/42088","code":true}]}]},"links":{"outbound_url":"https://doi.org/10.48713/10336_42088","outbound_label":"DOI","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Casallas Angel, Ingrid Lizeth","Oliver Hernández, Gabriel Antonio"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024-01-15","2024-01-31T12:19:20Z"]},{"key":"dc:publisher","label":"Institution","values":["Universidad del Rosario","Escuela de Medicina y Ciencias de la Salud","Especialización en Cardiología"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/bachelorThesis","info:eu-repo/semantics/acceptedVersion"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Miocarditis aguda","Infección viral","Resonancia magnética cardiaca","Electrocardiografía","Ecocardiografía","Acute myocarditis","Viral infection","Cardiac magnetic resonance","Electrocardiography","Echocardiography"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["spa"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess","http://creativecommons.org/licenses/by-nc-sa/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://doi.org/10.48713/10336_42088","https://repository.urosario.edu.co/handle/10336/42088"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["La miocarditis es un trastorno inflamatorio del miocardio que puede ocurrir secundario a una infección, respuesta inmune o toxicidad. Registros globales de carga de enfermedad han reportado una incidencia de 14 a 22 casos por 100.000 pacientes, 2/3 siendo hombres entre la tercera y cuarta década de la vida (1). Puede presentarse de forma, aguda, subaguda, crónica o fulminante según el tiempo de evolución y su severidad, siendo la miocarditis aguda y fulminante aquellas mayormente asociadas a cuadro complicados por shock cardiogénico y representando una causa importante de morbimortalidad cardiovascular en adultos jóvenes (2). Por lo cual este trabajo busca describir las características y desenlaces presentes en adultos con miocarditis aguda en una cohorte retrospectiva de la fundación Cardioinfantil – Lacardio 2017-2022.","Myocarditis is an inflammatory disorder of the myocardium that can occur secondary to infection, immune response, or toxicity. Global burden of disease registries have reported an incidence of 14 to 22 cases per 100,000 patients, 2/3 being men between the third and fourth decade of life (1). It can present in an acute, subacute, chronic or fulminant form depending on the time of evolution and its severity, with acute and fulminant myocarditis being those mostly associated with conditions complicated by cardiogenic shock and representing an important cause of cardiovascular morbidity and mortality in young adults (2). . Therefore, this work seeks to describe the characteristics and outcomes present in adults with acute myocarditis in a retrospective cohort of the Cardioinfantil – Lacardio foundation 2017-2022."]},{"key":"dc:format","label":"Dc Format","values":["39 pp","application/pdf"]},{"key":"dc:source","label":"Dc Source","values":["Tschöpe, Carsten et al. Myocarditis and Inflammatory Cardiomyopathy: Current Evidence and Future Directions. Nat Rev Cardiol [Internet]. 2020;18(12):1–25.","Ammirati E, Cipriani M, Moro C et al. Registro Lombardo delle Miocarditi. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: Multicenter Lombardy Registry. Circulation. 2018;138(11):1088–99.","Younis A, Matetzky S MW et al. Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. J Am Coll Cardiol. 2020;76(25):2982–3021.","Roth GA, Mensah GA, Johnson CO et al. GBD-NHLBI-JACC Global Burden of Cardiovascular DiseasesWriting Group. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.","Ammirati E, Moslehi JJ et. al. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA - J Am Med Assoc. 2023;329(13):1098–113.","Y.Y. Zheng, Y.T. Ma, J.Y. Zhang, X. Xie et. al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–60.","Lehmann LH, Cautela J, Palaskas N et al. Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor-associated myocarditis: a narrative review. JAMA - J Am Med Assoc. 2021;6(11):1329–37.","Nunes MCP, Beaton A, Acquatella H et al. American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Chagas cardiomyopathy: an update of current cl. Circulation. 2018;138(12):e169–209.","Cooper LT, Baughman KL, Feldman AM et al. American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of . Circulation. 2007;116(19):2216–33.","Rincón-Acevedo CY, Parada-Garc.a AS, OliveraMJ et al. . Clinical and epidemiological characterization of acute Chagas disease in Casanare, Eastern Colombia, 2012-2020. Frontiers (Boulder). 2021;8(681–690).","Caforio AL, Pankuweit S, Arbustini E et al. European Society of CardiologyWorking Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy ofmyocarditis: a position statement of the European Society of CardiologyWorking Group on Myoca. Eur Heart J. 2013;34(33):2636–48.","Lyon AR, L.pez-Fern.ndez T, Couch LS et al. ESC Scientific Document Group. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Soci. Eur Heart J. 2022;43(41):4229–361.","Cooper LT Jr, Hare JM, Tazelaar HD et al. Giant Cell Myocarditis Treatment Trial Investigators. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol. 2008;102(11):1535–9.","Kindermann, I, Barth, C, Mahfoud F et al. Update on Myocarditis. J Am Coll Cardiol. 2012;59(9):779–92.","Ammirati E, Veronese G, Brambatti M et al. Fulminant versus acute nonfulminantmyocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019;74(3):299–311.","Basso C. Myocarditis. N Engl J Med. 2022;387:1488–500.","Piccirillo, F., Watanabe, M., Di Sciascio G. Diagnosis, treatment and predictors of prognosis of myocarditis. A narrative review. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2021;54:107362.","Lampejo, T., Durkin, S. M., Bhatt, N., Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med (Northfield Il). 2021;21(5):e505–10.","Sagar, S., Liu, P. P., Cooper, L. T. J. Myocarditis. Lancet. 2012;379(9817):738–47.","Ammirati, E., Moslehi JJ. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA - J Am Med Assoc. 2023;329(13):1098–113.","Logstrup BB, Nielsen JM, KimWY PS. Myocardial oedema in acutemyocarditis detected by echocardiographic 2Dmyocardial deformation analysis. Eur Heart J. 2016;17(9):1018–26. 22. Krishna A, Kumar S, Kumar A, Prasad U. ECG manifestation in dengue fever. Int J Health Clin Res. 2021;4(1):292–297.17.","Hakami A, Moafa A, Alomaish A, Mashraqi M. Bradyarrhythmia in COVID-19 Patients. Cureus. 2021 Nov 8;13(11):e19367.","Pershad, J. (2002). Persistent sinus bradycardia: an unusual presentation of acute myocarditis in infancy. Clinical Intensive Care, 13(2-3), 119–121. doi:10.3109/tcic.13.2-3.119.121","Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., … Adler, Y. (2013). A Randomized Trial of Colchicine for Acute Pericarditis. New England Journal of Medicine, 369(16), 1522–1528. doi:10.1056/nejmoa1208536.","Médica Mundial, Helsinki, Finlandia, junio 1964 y enmendada por la 29ª Asamblea Médica Mundial, Tokio, Japón, octubre 1975 35ª Asamblea Médica Mundial, Venecia, Italia, octubre 1983 41ª Asamblea Médica Mundial, Hong Kong, septiembre 1989 48ª Asamblea General Somerset West, Sudáfrica, octubre 1996 52ª Asamblea General, Edimburgo, Escocia, octubre 2000 Nota de Clarificación, agregada por la Asamblea General de la AMM, Washington 2002 Nota de Clarificación, agregada por la Asamblea General de la AMM, Tokio 2004 59ª Asamblea General, Seúl, Corea, octubre 2008 64ª Asamblea General, Fortaleza, Brasil, octubre 2013.","instname:Universidad del Rosario","reponame:Repositorio Institucional EdocUR"]},{"key":"dc:title","label":"Title","values":["Caracterización y desenlaces asociados al desarrollo de miocarditis en una cohorte retrospectiva. Fundación Cardioinfantil - Lacardio 2017 - 2022","Characterization and outcomes associated with the development of myocarditis in a retrospective cohort. Cardioinfantil Foundation - Lacardio 2017 - 2022"]}]}],"canonical_facts":{"dc:creator":["Casallas Angel, Ingrid Lizeth","Oliver Hernández, Gabriel Antonio"],"dc:date":["2024-01-15","2024-01-31T12:19:20Z"],"dc:description":["La miocarditis es un trastorno inflamatorio del miocardio que puede ocurrir secundario a una infección, respuesta inmune o toxicidad. Registros globales de carga de enfermedad han reportado una incidencia de 14 a 22 casos por 100.000 pacientes, 2/3 siendo hombres entre la tercera y cuarta década de la vida (1). Puede presentarse de forma, aguda, subaguda, crónica o fulminante según el tiempo de evolución y su severidad, siendo la miocarditis aguda y fulminante aquellas mayormente asociadas a cuadro complicados por shock cardiogénico y representando una causa importante de morbimortalidad cardiovascular en adultos jóvenes (2). Por lo cual este trabajo busca describir las características y desenlaces presentes en adultos con miocarditis aguda en una cohorte retrospectiva de la fundación Cardioinfantil – Lacardio 2017-2022.","Myocarditis is an inflammatory disorder of the myocardium that can occur secondary to infection, immune response, or toxicity. Global burden of disease registries have reported an incidence of 14 to 22 cases per 100,000 patients, 2/3 being men between the third and fourth decade of life (1). It can present in an acute, subacute, chronic or fulminant form depending on the time of evolution and its severity, with acute and fulminant myocarditis being those mostly associated with conditions complicated by cardiogenic shock and representing an important cause of cardiovascular morbidity and mortality in young adults (2). . Therefore, this work seeks to describe the characteristics and outcomes present in adults with acute myocarditis in a retrospective cohort of the Cardioinfantil – Lacardio foundation 2017-2022."],"dc:format":["39 pp","application/pdf"],"dc:identifier":["https://doi.org/10.48713/10336_42088","https://repository.urosario.edu.co/handle/10336/42088"],"dc:language":["spa"],"dc:publisher":["Universidad del Rosario","Escuela de Medicina y Ciencias de la Salud","Especialización en Cardiología"],"dc:rights":["info:eu-repo/semantics/openAccess","http://creativecommons.org/licenses/by-nc-sa/4.0/"],"dc:source":["Tschöpe, Carsten et al. Myocarditis and Inflammatory Cardiomyopathy: Current Evidence and Future Directions. Nat Rev Cardiol [Internet]. 2020;18(12):1–25.","Ammirati E, Cipriani M, Moro C et al. Registro Lombardo delle Miocarditi. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: Multicenter Lombardy Registry. Circulation. 2018;138(11):1088–99.","Younis A, Matetzky S MW et al. Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. J Am Coll Cardiol. 2020;76(25):2982–3021.","Roth GA, Mensah GA, Johnson CO et al. GBD-NHLBI-JACC Global Burden of Cardiovascular DiseasesWriting Group. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.","Ammirati E, Moslehi JJ et. al. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA - J Am Med Assoc. 2023;329(13):1098–113.","Y.Y. Zheng, Y.T. Ma, J.Y. Zhang, X. Xie et. al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–60.","Lehmann LH, Cautela J, Palaskas N et al. Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor-associated myocarditis: a narrative review. JAMA - J Am Med Assoc. 2021;6(11):1329–37.","Nunes MCP, Beaton A, Acquatella H et al. American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Chagas cardiomyopathy: an update of current cl. Circulation. 2018;138(12):e169–209.","Cooper LT, Baughman KL, Feldman AM et al. American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of . Circulation. 2007;116(19):2216–33.","Rincón-Acevedo CY, Parada-Garc.a AS, OliveraMJ et al. . Clinical and epidemiological characterization of acute Chagas disease in Casanare, Eastern Colombia, 2012-2020. Frontiers (Boulder). 2021;8(681–690).","Caforio AL, Pankuweit S, Arbustini E et al. European Society of CardiologyWorking Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy ofmyocarditis: a position statement of the European Society of CardiologyWorking Group on Myoca. Eur Heart J. 2013;34(33):2636–48.","Lyon AR, L.pez-Fern.ndez T, Couch LS et al. ESC Scientific Document Group. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Soci. Eur Heart J. 2022;43(41):4229–361.","Cooper LT Jr, Hare JM, Tazelaar HD et al. Giant Cell Myocarditis Treatment Trial Investigators. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol. 2008;102(11):1535–9.","Kindermann, I, Barth, C, Mahfoud F et al. Update on Myocarditis. J Am Coll Cardiol. 2012;59(9):779–92.","Ammirati E, Veronese G, Brambatti M et al. Fulminant versus acute nonfulminantmyocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019;74(3):299–311.","Basso C. Myocarditis. N Engl J Med. 2022;387:1488–500.","Piccirillo, F., Watanabe, M., Di Sciascio G. Diagnosis, treatment and predictors of prognosis of myocarditis. A narrative review. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2021;54:107362.","Lampejo, T., Durkin, S. M., Bhatt, N., Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med (Northfield Il). 2021;21(5):e505–10.","Sagar, S., Liu, P. P., Cooper, L. T. J. Myocarditis. Lancet. 2012;379(9817):738–47.","Ammirati, E., Moslehi JJ. Diagnosis and Treatment of Acute Myocarditis: A Review. JAMA - J Am Med Assoc. 2023;329(13):1098–113.","Logstrup BB, Nielsen JM, KimWY PS. Myocardial oedema in acutemyocarditis detected by echocardiographic 2Dmyocardial deformation analysis. Eur Heart J. 2016;17(9):1018–26. 22. Krishna A, Kumar S, Kumar A, Prasad U. ECG manifestation in dengue fever. Int J Health Clin Res. 2021;4(1):292–297.17.","Hakami A, Moafa A, Alomaish A, Mashraqi M. Bradyarrhythmia in COVID-19 Patients. Cureus. 2021 Nov 8;13(11):e19367.","Pershad, J. (2002). Persistent sinus bradycardia: an unusual presentation of acute myocarditis in infancy. Clinical Intensive Care, 13(2-3), 119–121. doi:10.3109/tcic.13.2-3.119.121","Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., … Adler, Y. (2013). A Randomized Trial of Colchicine for Acute Pericarditis. New England Journal of Medicine, 369(16), 1522–1528. doi:10.1056/nejmoa1208536.","Médica Mundial, Helsinki, Finlandia, junio 1964 y enmendada por la 29ª Asamblea Médica Mundial, Tokio, Japón, octubre 1975 35ª Asamblea Médica Mundial, Venecia, Italia, octubre 1983 41ª Asamblea Médica Mundial, Hong Kong, septiembre 1989 48ª Asamblea General Somerset West, Sudáfrica, octubre 1996 52ª Asamblea General, Edimburgo, Escocia, octubre 2000 Nota de Clarificación, agregada por la Asamblea General de la AMM, Washington 2002 Nota de Clarificación, agregada por la Asamblea General de la AMM, Tokio 2004 59ª Asamblea General, Seúl, Corea, octubre 2008 64ª Asamblea General, Fortaleza, Brasil, octubre 2013.","instname:Universidad del Rosario","reponame:Repositorio Institucional EdocUR"],"dc:subject":["Miocarditis aguda","Infección viral","Resonancia magnética cardiaca","Electrocardiografía","Ecocardiografía","Acute myocarditis","Viral infection","Cardiac magnetic resonance","Electrocardiography","Echocardiography"],"dc:title":["Caracterización y desenlaces asociados al desarrollo de miocarditis en una cohorte retrospectiva. Fundación Cardioinfantil - Lacardio 2017 - 2022","Characterization and outcomes associated with the development of myocarditis in a retrospective cohort. Cardioinfantil Foundation - Lacardio 2017 - 2022"],"dc:type":["info:eu-repo/semantics/bachelorThesis","info:eu-repo/semantics/acceptedVersion"]},"updated_at":"2026-07-27T20:46:27Z"}